{"status":"ok","message-type":"event-list","message":{"next-cursor":"2980eb91-672f-c517-6906-18c03e8c9928","total-results":2,"items-per-page":1000,"events":[{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.03039.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2014-03-18T00:00:00Z","subj_id":"https:\/\/lens.org\/002-012-069-828-086","id":"9b918412-9262-dc89-d1af-82c06d5254da","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Granted Patent","work_type_id":"patent","title":"Targeting Of Cd8+ T-Lymphocytes To Treat Neurodegenerative Diseases","pid":"https:\/\/lens.org\/002-012-069-828-086","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T03:11:04Z","relation_type_id":"cites"},{"license":"https:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/","obj_id":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.03039.x","source_token":"1ad0b713-78ed-4bb9-8d5d-a3c2d163d46f","occurred_at":"2012-09-20T00:00:00Z","subj_id":"https:\/\/lens.org\/093-810-894-282-404","id":"2980eb91-672f-c517-6906-18c03e8c9928","terms":"https:\/\/doi.org\/10.13003\/CED-terms-of-use","action":"add","subj":{"work_subtype_id":"Patent Application","work_type_id":"patent","title":"Targeting Of Cd8+ T-Lymphocytes To Treat Neurodegenerative Diseases","pid":"https:\/\/lens.org\/093-810-894-282-404","jurisdiction":"US"},"source_id":"cambia-lens","timestamp":"2017-11-11T22:49:52Z","relation_type_id":"cites"}]}}